Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Bellicum Pharmaceuticals, Inc (BLCM)  
$0.07 0.00 (0.00%) as of 4:30 Mon 3/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,100,000
Market Cap: 455.98(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0745 - $0.96
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for the treatment of various forms of cancer. Co. is developing chimeric antigen receptors (CAR)-T cell therapies, which are an approach in which a patient's or donor's T cells are genetically modified to carry CARs. By incorporating its switch technologies, Co. is developing product candidates in various areas of cellular immunotherapy including BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; and BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 179
  Page 3 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Naeve Gregory S. Chief Business Officer   •       –      –    2019-01-02 4 D $3.33 $3,307 D/D (993) 14,441     -
   Naeve Gregory S. Chief Business Officer   •       –      –    2019-01-02 4 OE $0.00 $0 D/D 2,031 15,434     -
   Spencer David M. Chief Technology Officer   •       –      –    2019-01-02 4 D $3.33 $3,137 D/D (942) 91,497     -
   Spencer David M. Chief Technology Officer   •       –      –    2019-01-02 4 OE $0.00 $0 D/D 2,500 92,439     -
   Smith Alan K. EVP, Technical Operations   •       –      –    2019-01-02 4 D $3.33 $2,940 D/D (883) 3,548     -
   Smith Alan K. EVP, Technical Operations   •       –      –    2019-01-02 4 OE $0.00 $0 D/D 2,344 4,431     -
   Williams Rosemary Y. Principal Accounting Officer   •       –      –    2019-01-02 4 D $3.33 $1,608 D/D (483) 3,984     -
   Williams Rosemary Y. Principal Accounting Officer   •       –      –    2019-01-02 4 OE $0.00 $0 D/D 1,281 4,467     -
   Stonehouse Jon P Director   –       •      –    2018-11-09 4 B $4.56 $45,600 D/D 10,000 10,000 2.39     -
   Spencer David M. Chief Technology Officer   •       –      –    2018-09-04 4 AS $7.04 $70,413 D/D (10,000) 89,939     -
   Naeve Gregory S. Chief Business Officer   •       –      –    2018-08-21 4 D $6.74 $10,764 D/D (1,597) 13,403     -
   Spencer David M. Chief Technology Officer   •       –      –    2018-07-18 4 AS $7.63 $305,132 D/D (40,000) 99,939     -
   Ward Shane Sr. VP and General Counsel   •       –      –    2018-05-29 4 A $0.00 $0 D/D 10,000 10,000     -
   Musso Alan A CFO and Treasurer   •       –      –    2018-05-25 4 AS $7.97 $49,466 D/D (6,206) 26,548     -
   Grossman William Sr. VP, Chief Medical Officer   •       –      –    2018-02-05 4 A $0.00 $0 D/D 30,000 30,000     -
   Baker Julian 10% Owner   –       –       •   2018-01-19 4 S $7.91 $2,336,217 I/I (295,361) 58,131     -
   Baker Julian 10% Owner   –       –       •   2018-01-18 4 S $8.12 $2,635,768 I/I (324,774) 62,267     -
   Baker Julian 10% Owner   –       –       •   2018-01-17 4 S $8.63 $2,247,910 I/I (260,600) 66,815     -
   Smith Alan K. EVP, Technical Operations   •       –      –    2018-01-09 4 AS $9.40 $4,578 D/D (487) 2,087     -
   Spencer David M. Chief Scientific Officer   •       –      –    2018-01-03 4 D $9.79 $5,766 D/D (589) 139,939     -
   Spencer David M. Chief Scientific Officer   •       –      –    2018-01-03 4 OE $0.00 $0 D/D 1,563 140,528     -
   Musso Alan A CFO and Treasurer   •       –      –    2018-01-03 4 D $9.79 $6,912 D/D (706) 32,754     -
   Musso Alan A CFO and Treasurer   •       –      –    2018-01-03 4 OE $0.00 $0 D/D 1,875 33,460     -
   Moseley Ken Sr. VP and General Counsel   •       –      –    2018-01-03 4 D $9.79 $5,766 D/D (589) 1,465     -
   Moseley Ken Sr. VP and General Counsel   •       –      –    2018-01-03 4 OE $0.00 $0 D/D 1,563 2,054     -

  179 Records found
  1  2  3  4  5  6  7  8   
  Page 3 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed